XXII director files Form 4: 17,295 RSUs, 51,888 options grant
22nd Century Group (XXII) director Andrew Arno reported equity awards.
Rhea-AI Filing Summary
22nd Century Group (XXII) director Andrew Arno reported equity awards. On 11/10/2025, he acquired 17,295 shares of common stock for $0, described as restricted stock units that vest 1/3 each on November 10, 2026, 2027, and 2028, subject to continued service. He also received a non‑qualified stock option for 51,888 shares at an exercise price of $1.27, expiring 11/10/2035, vesting 1/3 annually on the grant anniversary.
Following the reported transactions, common stock beneficially owned was 17,481 shares, held directly. The filing also lists an existing option for 553 shares at $46.23, expiring 03/10/2035. Share amounts reflect a 1‑for‑23 stock split effective June 20, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option | 51,888 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 17,295 | $0.00 | $0.00 |
| holding | Non-Qualified Stock Option | -- | -- | -- |
Footnotes (3)
- F1. The restricted stock units vest 1/3 per year on November 10, 2026, 2027 and 2028, subject to continued service with the Company.
- F2. The amount shown reflects the number of shares held following the reported transaction, as adjusted for a 1-for-23 stock split effectuated by the issuer on June 20, 2025.
- F3. Options vest 1/3 per year on the anniversary of the date of grant, subject to continued service with the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did 22nd Century Group (XXII) disclose in this Form 4?
What is the vesting schedule for the RSUs reported by XXII?
What are the key terms of the newly granted XXII stock option?
Were there other XXII options reported in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.